MacroGenics
Shengyan (Sam) Hong is a seasoned professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Vice President at MacroGenics, Inc., Shengyan also held positions as Executive Director and Sr. Director within the organization. Prior experience includes serving as Science Director at MedImmune and as Sr. Research Scientist at Eli Lilly and Company. Shengyan earned a Doctor of Philosophy (Ph.D.) in Statistics from Northwestern University between 1993 and 1998.
This person is not in any teams
This person is not in any offices
MacroGenics
1 followers
MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company devel...